T 2009/22 (Apixaban III/Bristol-Myers) of 31.01.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T200922.20240131
- Date of decision
- 31 January 2024
- Case number
- T 2009/22
- Online on
- 13 March 2024
- Petition for review of
- -
- Application number
- 17175788.3
- IPC class
- A61P 7/02A61K 9/20A61K 31/4545
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- APIXABAN FORMULATIONS
- Applicant name
- Bristol-Myers Squibb Holdings Ireland
Unlimited Company
Pfizer Inc. - Opponent name
- ZAKLADY FARMACEUTYCZNE POLPHARMA S.A.
Zentiva k.s.
Kutzenberger Wolff & Partner
Medichem S.A.
Teva Pharmaceutical Industries Ltd
Sandoz AG
Generics (U.K.) Limited
STADA Arzneimittel AG - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56
- Keywords
- Inventive step - (no)
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.